These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical efficacy of low-dose oral theophylline for treating mild asthma].
    Author: Huang SD, Yang J, Zhang SY, Tian LQ, Pan QH.
    Journal: Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):325-7. PubMed ID: 16546738.
    Abstract:
    OBJECTIVE: To observe the role of theophylline in relieving airway symptoms and inflammation in patients with mild asthma. METHODS: Fifty-six patients with mild asthma were randomly divided into treatment group (n=41) receiving oral theophylline at daily dose of 4 to 6 mg/kg for 16 weeks and control group (15 cases) without medication other than beta2 antagonist, which was administered when necessary in both groups. Peripheral blood T-lymphocyte subsets (CD3(+), CD4(+), and CD8(+)) and pulmonary function (PEF(am) and PD(20)) before and at 8 and 16 weeks during treatment were measured. RESULTS: Significant difference was observed in CD3+ and CD4(+) T-lymphocyte subsets after medication with theophylline (P<0.05) in the patients, and PEF(am) and PD(20) were also significantly different from those of the control group (P<0.05). Theophylline significantly improved the clinical symptom scores (P<0.05) and decreased the asthma attacks. CONCLUSION: Low-dose oral theophylline may significantly relieving airway inflammation in patients with mild asthma.
    [Abstract] [Full Text] [Related] [New Search]